hemodialysis (3)
Chronic kidney disease (2)
diabetes complications (2)
diabetic nephropathies (2)
hyperkalemia (2)
IgA nephropathy (2)
mineralocorticoid receptor antagonists (2)
ADPKD (1)
Albuminuria (1)
Albuminuria | Chronic kidney disease | Diabetic kidney disease | Finerenone | Hyperkalemia | SGLT2 inhibitor (1)
ANCA (1)
Anemia (1)
Anemia | IgA nephropathy | Primary glomerulonephritis (1)
autosomal dominant polycystic kidney disease (1)
autosomal dominant polycystic kidney disease | chronic kidney disease | COVID-19 (1)
BK virus nephropathy (1)
catheter complications (1)
catheter complications | Cox regression | end-stage renal disease | failure-free survival | hemodialysis | heparin-coated | tunneled catheter | vascular access (1)
Catheter thrombosis (1)
Catheter-related infection (1)
chronic inflammation (1)
chronic inflammation | CKD-MBD | hemodialysis | neutrophil-to-lymphocyte ratio | parathyroid hormone | systemic inflammation index (1)
chronic kidney disease (1)
Chronic kidney disease | global sclerotic glomeruli ratio | glomerulosclerosis | histopathology | idiopathic membranous nephropathy | prognostic marker | renal outcomes, tubular atrophy (1)
CKD-MBD (1)
Complement (1)
Complement deposition (1)
complication (1)
complication | diabetic | glycaemic control | haemodialysis | HbA1c (1)
Cooled ablation | Microwave ablation | Parathyroid adenoma | Parathyroid hormone | Uncooled ablation (1)
COVID-19 (1)
Cox regression (1)
diabetes complications | diabetic nephropathies | hyperkalemia | machine learning | mineralocorticoid receptor antagonists (1)
diabetes complications | diabetic nephropathies | hyperkalemia | mineralocorticoid receptor antagonists | retrospective study (1)
diabetic (1)
Diabetic kidney disease (1)
disaster (1)
disaster nephrology (1)
earthquake (1)
endovascular treatment (1)
end-stage renal disease (1)
erythrocyte membrane fatty acids (1)
erythrocyte membrane fatty acids | hemodialysis patients | hemoglobin | iron-restricted erythropoiesis | ZnPP (1)
failure-free survival (1)
fine-needle aspiration (1)
fine-needle aspiration | hydrodissection | parathyroid | parathyroid ablation | parathyroid embolization | primary hyperparathyroidism | PTH washout (1)
Finerenone (1)
Finerenone | Heart failure | Mineralocorticoid receptor antagonists | Nephropathy | Type 2 diabetes mellitus (1)
functional iron deficiency (1)
functional iron deficiency | hemodialysis patient | hypoxia | iron deficiency anemia | miRNA-210 (1)
Glomerulonephritis (1)
Glomerulosclerosis (1)
Glomerulosclerosis | IgA nephropathy | Kidney outcome | Prognostic index (1)
glycaemic control (1)
graft dysfunction (1)
graft Loss (1)
haemodialysis (1)
HbA1c (1)
Hemodialysis (1)
hemodialysis patient (1)
hemodialysis patients (1)
hemoglobin (1)
Heparin lock (1)
heparin-coated (1)
hydrodissection (1)
Hyperkalemia (1)
hypoxia (1)
influenza (1)
iron deficiency anemia (1)
iron-restricted erythropoiesis (1)
ischemic stroke (1)
kidney biopsy (1)
Kidney outcome (1)
kidney transplantation (1)
machine learning (1)
miRNA-210 (1)
neutrophil-to-lymphocyte ratio (1)
Non-tunneled dialysis catheter (1)
parathyroid (1)
parathyroid ablation (1)
parathyroid embolization (1)
parathyroid hormone (1)
peritoneal dialysis (1)
peritonitis (1)
pneumococcal pneumonia (1)
Primary glomerulonephritis (1)
primary hyperparathyroidism (1)
Prognostic index (1)
PTH washout (1)
retrospective study (1)
SGLT2 inhibitor (1)
Sodium bicarbonate (1)
systemic inflammation index (1)
Thirst sensation and intensity (1)
Tolvaptan (1)
tunneled catheter (1)
vaccine (1)
vascular access (1)
ZnPP (1)